BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
jupiter life line hosp l stock

JUPITER LIFE LINE HOSP L Share Price

1557.9 -41.25 (-2.57%)
Dec 12 2024 03:29 PM Healthcare NSE: JLHL

JUPITER LIFE LINE HOSP L Share Price Update

As of the latest trading session, JUPITER LIFE LINE HOSP L share price is currently at 1557.9, which is down by -41.25 from its previous closing. Today, the stock has fluctuated between 1550.55 and 1619.90. Over the past year, JUPITER LIFE LINE HOSP L has achieved a return of 44.22 %. In the last month alone, the return has been 8.08 %. Read More...

JUPITER LIFE LINE HOSP L Performance

Day Range

Low1550.55 High1619.90
1558.90

52 Week Range

Low 1050.00 High 1653.95
1558.90

JUPITER LIFE LINE HOSP L Share Price

18553

543980

JLHL

img img img img
No Data Available

Open Price

1599.15

Prev. Close

1599.15

Volume (Shares)

31341.00

Total traded value

488.57

Upper Circuit

1918.95

Lower Circuit

1279.35

Note: The current prices & values are delayed, Login to your account for live updates.

JUPITER LIFE LINE HOSP L Fundamentals


(Standalone)

Market Cap (Cr) 10214.53
PE Ratio (TTM) 58.02
Book Value / Share 202.79
Beta 0.42
ROE 17.77%
EPS (TTM) 26.66
Dividend Yield 0.06%
Net Profit Qtr (Cr) 50.30

JUPITER LIFE LINE HOSP L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 273.10
Operating Expense 215.07
Net Profit 50.30
Net Profit Margin (%) 18.41
Earnings Per Share (EPS) 7.67
EBITDA 78.70
Effective Tax Rate (%) 25.26
Particulars JUN 2024 (Values in Cr)
Revenue 239.41
Operating Expense 192.66
Net Profit 40.65
Net Profit Margin (%) 16.97
Earnings Per Share (EPS) 6.20
EBITDA 63.92
Effective Tax Rate (%) 26.07
Particulars MAR 2024 (Values in Cr)
Revenue 245.31
Operating Expense 197.33
Net Profit 43.15
Net Profit Margin (%) 17.58
Earnings Per Share (EPS) 6.47
EBITDA 67.41
Effective Tax Rate (%) 26.89
Particulars DEC 2023 (Values in Cr)
Revenue 230.38
Operating Expense 181.98
Net Profit 42.24
Net Profit Margin (%) 18.33
Earnings Per Share (EPS) 6.48
EBITDA 64.82
Effective Tax Rate (%) 24.80
Particulars SEP 2023 (Values in Cr)
Revenue 227.07
Operating Expense 184.42
Net Profit 36.13
Net Profit Margin (%) 15.91
Earnings Per Share (EPS) 6.18
EBITDA 64.20
Effective Tax Rate (%) 24.79
Particulars MAR 2024 (Values in Cr)
Revenue 910.63
Operating Expense 736.44
Net Profit 151.95
Net Profit Margin (%) 16.68
Earnings Per Share (EPS) 24.89
EBITDA 253.00
Effective Tax Rate (%) 25.44
Particulars MAR 2023 (Values in Cr)
Revenue 787.32
Operating Expense 639.61
Net Profit 107.21
Net Profit Margin (%) 13.61
Earnings Per Share (EPS) 20.58
EBITDA 215.20
Effective Tax Rate (%) 32.52
Particulars MAR 2022 (Values in Cr)
Revenue 657.28
Operating Expense 555.32
Net Profit 84.67
Net Profit Margin (%) 12.88
Earnings Per Share (EPS) 16.65
EBITDA 162.60
Effective Tax Rate (%) 19.90
Particulars MAR 2021 (Values in Cr)
Revenue 461.10
Operating Expense 447.58
Net Profit 16.59
Net Profit Margin (%) 3.59
Earnings Per Share (EPS) 3.26
EBITDA 73.10
Effective Tax Rate (%) 5.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 178.30
ROE % 23.02
ROCE % 22.10
Total Debt to Total Equity 0.31
EBITDA Margin 24.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 64.70
ROE % 22.12
ROCE % 21.07
Total Debt to Total Equity 1.46
EBITDA Margin 23.48
Particulars MAR 2022 (Values in Cr)
Book Value / Share 57.36
ROE % 19.20
ROCE % 16.66
Total Debt to Total Equity 1.73
EBITDA Margin 21.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 46.98
ROE % -0.97
ROCE % 6.91
Total Debt to Total Equity 1.47
EBITDA Margin 14.66
Particulars MAR 2020 (Values in Cr)
Book Value / Share 46.54
ROE % 12.52
ROCE % 11.52
Total Debt to Total Equity 1.15
EBITDA Margin 18.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 189.92
ROE % 17.77
ROCE % 22.13
Total Debt to Total Equity 0.17
EBITDA Margin 27.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 82.28
ROE % 27.01
ROCE % 26.40
Total Debt to Total Equity 0.78
EBITDA Margin 27.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.30
ROE % 29.09
ROCE % 23.16
Total Debt to Total Equity 1.00
EBITDA Margin 24.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 49.80
ROE % 6.77
ROCE % 9.02
Total Debt to Total Equity 1.07
EBITDA Margin 15.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 46.54
ROE % 13.17
ROCE % 12.14
Total Debt to Total Equity 1.14
EBITDA Margin 18.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 301.25
Total Assets 1281.33
Total Liabilities 1281.33
Total Equity 1168.73
Share Outstanding 65566022
Price to Book Ratio 6.31
Return on Assets (%) 13.78
Return on Capital (%) 15.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 134.46
Total Assets 985.53
Total Liabilities 985.53
Total Equity 363.91
Share Outstanding 56518390
Price to Book Ratio 0.00
Return on Assets (%) 7.39
Return on Capital (%) 8.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 103.36
Total Assets 908.69
Total Liabilities 908.69
Total Equity 288.43
Share Outstanding 50866551
Price to Book Ratio 0.00
Return on Assets (%) 5.62
Return on Capital (%) 6.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 19.43
Total Assets 788.90
Total Liabilities 788.90
Total Equity 246.44
Share Outstanding 50866551
Price to Book Ratio 0.00
Return on Assets (%) -0.29
Return on Capital (%) -0.34
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.97
Total Assets 602.92
Total Liabilities 602.92
Total Equity 236.73
Share Outstanding 50866551
Price to Book Ratio 0.00
Return on Assets (%) 4.91
Return on Capital (%) 5.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 297.19
Total Assets 1360.59
Total Liabilities 1360.59
Total Equity 1245.25
Share Outstanding 65566022
Price to Book Ratio 6.31
Return on Assets (%) 11.16
Return on Capital (%) 12.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 133.30
Total Assets 885.33
Total Liabilities 885.33
Total Equity 465.02
Share Outstanding 56518390
Price to Book Ratio 0.00
Return on Assets (%) 12.10
Return on Capital (%) 14.06
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 102.15
Total Assets 754.74
Total Liabilities 754.74
Total Equity 328.87
Share Outstanding 50866551
Price to Book Ratio 0.00
Return on Assets (%) 11.21
Return on Capital (%) 13.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.46
Total Assets 614.56
Total Liabilities 614.56
Total Equity 253.33
Share Outstanding 50866551
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 3.22
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.95
Total Assets 593.55
Total Liabilities 593.55
Total Equity 236.74
Share Outstanding 50866551
Price to Book Ratio 0.00
Return on Assets (%) 4.99
Return on Capital (%) 6.04
Particulars MAR 2024 (Values in Cr)
Net Income 195.41
Cash from Operations 164.20
Cash from Investing -75.88
Cash from Financing 128.15
Net change in Cash 166.78
Free Cash Flow 249.49
Particulars MAR 2023 (Values in Cr)
Net Income 128.70
Cash from Operations 150.46
Cash from Investing -103.56
Cash from Financing 17.50
Net change in Cash 31.09
Free Cash Flow 227.71
Particulars MAR 2022 (Values in Cr)
Net Income 77.11
Cash from Operations 145.59
Cash from Investing -85.24
Cash from Financing 32.20
Net change in Cash 83.92
Free Cash Flow 237.32
Particulars MAR 2021 (Values in Cr)
Net Income 1.55
Cash from Operations 133.20
Cash from Investing -295.84
Cash from Financing 184.29
Net change in Cash 11.85
Free Cash Flow 374.78
Particulars MAR 2020 (Values in Cr)
Net Income 32.88
Cash from Operations 89.32
Cash from Investing -43.38
Cash from Financing -31.73
Net change in Cash -0.91
Free Cash Flow 117.91
Particulars MAR 2024 (Values in Cr)
Net Income 203.82
Cash from Operations 159.47
Cash from Investing -256.48
Cash from Financing 310.57
Net change in Cash 163.88
Free Cash Flow 235.82
Particulars MAR 2023 (Values in Cr)
Net Income 158.88
Cash from Operations 217.32
Cash from Investing -129.65
Cash from Financing -23.22
Net change in Cash 31.14
Free Cash Flow 260.58
Particulars MAR 2022 (Values in Cr)
Net Income 105.71
Cash from Operations 150.96
Cash from Investing -68.92
Cash from Financing 9.66
Net change in Cash 83.08
Free Cash Flow 217.31
Particulars MAR 2021 (Values in Cr)
Net Income 17.54
Cash from Operations 123.49
Cash from Investing -78.21
Cash from Financing -23.42
Net change in Cash 11.50
Free Cash Flow 145.57
Particulars MAR 2020 (Values in Cr)
Net Income 32.88
Cash from Operations 89.71
Cash from Investing -43.38
Cash from Financing -32.14
Net change in Cash -0.92
Free Cash Flow 118.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 89.24 14.08 105571.01 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.99 0.00 3.95 118.05 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.66 0.00 5.35 58.04 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7342.30 94.01 12.88 105571.01 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 54.13 0.00 -28.99 40.44 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5427.00 29.43 6.09 5937.14 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1573.70
  • 26 Days 1499.80
  • 10 Days 1551.60
  • 50 Days 1462.00
  • 12 Days 1550.10
  • 100 Days 1409.40
  • 20 Days 1530.10
  • 200 Days 1418.90
1608.23
PIVOT
First Resistance 1637.92
Second Resistance 1676.68
Third Resistance 1706.37
First Support 1569.47
Second Support 1539.78
Third Support 1501.02
RSI 71.83
MACD 50.28
Commodity Channel Index (CCI) 214.08
ADX 47.56
Williams % R -25.84

Over 1 Month

down

8.08

Over 3 Months

down

19.96

Over 6 Months

down

30.25

Over 1 Year

down

44.22

Over 3 Years

down

0.00

Over 5 Years

down

0.00

JUPITER LIFE LINE HOSP L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

JUPITER LIFE LINE HOSP L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
33.37
Promoter Holdings
40.91
FII
8.84
DII
16.87
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ajay P Thakker Shareholding of Promoter and Promoter Group 1.3597829E7 20.74
Western Medical Solutions Llp Shareholding of Promoter and Promoter Group 5703797.0 8.7
Sbi Healthcare Opportunities Fund Public Shareholding 5369546.0 8.19
Ankit Thakker Shareholding of Promoter and Promoter Group 4375789.0 6.67
Jm Financial Products Limited Public Shareholding 2240000.0 3.42
Kamini Arvind Rao Public Shareholding 2144600.0 3.27
Goldman Sachs Funds - Goldman Sachs India Equity P Public Shareholding 1474920.0 2.25
Nitin Manilal Thakker Public Shareholding 1420000.0 2.17
Mihir Wire Industries Pvt Ltd Public Shareholding 1410000.0 2.15
Neeta Devang Gandhi Shareholding of Promoter and Promoter Group 1380000.0 2.1
Kirtika Ajay Thakker Shareholding of Promoter and Promoter Group 1332750.0 2.03
Dr Navin Ramji Davda Public Shareholding 1314000.0 2.0
J M Financial And Investment Consultancy Services Public Shareholding 1250000.0 1.91
Ramakant Jagdish Tibrewala Public Shareholding 1225000.0 1.87
Brijesh Ramakant Tibrewala Public Shareholding 1191772.0 1.82
Mahesh Ramakant Tibrewala Public Shareholding 1191736.0 1.82
Custody Bank Of Japan, Ltd. Re: Rb Amundi India Sm Public Shareholding 1000000.0 1.53
Snk Investments Private Limited Public Shareholding 910000.0 1.39
Sushma Ramakant Tibrewala Public Shareholding 808000.0 1.23
Rajesh Hiralal Vora Public Shareholding 800000.0 1.22
A S Arvind Public Shareholding 790625.0 1.21
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund Public Shareholding 673974.0 1.03
Devang Vasantlal Gandhi Shareholding of Promoter and Promoter Group 410000.0 0.63
Nikita Ankit Thakker Shareholding of Promoter and Promoter Group 16000.0 0.02
Ajay P Thakker Huf Shareholding of Promoter and Promoter Group 9458.0 0.01

JUPITER LIFE LINE HOSP L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About JUPITER LIFE LINE HOSP L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by JUPITER LIFE LINE HOSP L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Jupiter Life Line Hospitals Ltd?

Answer Field

The share price of Jupiter Life Line Hospitals Ltd for NSE is ₹ 1557.9 and for BSE is ₹ 1556.

What is the Market Cap of Jupiter Life Line Hospitals Ltd?

Answer Field

The market cap of Jupiter Life Line Hospitals Ltd for NSE is ₹ 1,02,14.53 Cr. and for BSE is ₹ 1,02,02.07 Cr. as of now.

What is the 52 Week High and Low of Jupiter Life Line Hospitals Ltd?

Answer Field

The 52 Week High and Low of Jupiter Life Line Hospitals Ltd for NSE is ₹ 1653.95 and ₹ 1050.00 and for BSE is ₹ 1648.60 and ₹ 1037.40.

How to Buy Jupiter Life Line Hospitals Ltd share?

Answer Field

You can trade in Jupiter Life Line Hospitals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Jupiter Life Line Hospitals Ltd?

Answer Field

The 1 year returns on the stock has been 44.22%.

What is the Current Share Price of Jupiter Life Line Hospitals Ltd?

Answer Field

Jupiter Life Line Hospitals Ltd share price is for NSE ₹ 1557.9 & for BSE ₹ 1556 as on Dec 12 2024 03:29 PM.

What is the Market Cap of Jupiter Life Line Hospitals Ltd Share?

Answer Field

The market cap of Jupiter Life Line Hospitals Ltd for NSE ₹ 1,02,14.53 & for BSE ₹ 1,02,02.07 as on Dec 12 2024 03:29 PM.

What is the P/E Ratio of Jupiter Life Line Hospitals Ltd Share?

Answer Field

As on Dec 12 2024 03:29 PM the price-to-earnings (PE) ratio for Jupiter Life Line Hospitals Ltd share is 58.02.

What is the PB ratio of Jupiter Life Line Hospitals Ltd Share?

Answer Field

As on Dec 12 2024 03:29 PM, the price-to-book (PB) ratio for Jupiter Life Line Hospitals Ltd share is 202.79.

How to Buy Jupiter Life Line Hospitals Ltd Share?

Answer Field

You can trade in Jupiter Life Line Hospitals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jupiter Life Line Hospitals Ltd Share on Bajaj Broking App?

Answer Field

To buy Jupiter Life Line Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jupiter Life Line Hospitals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader